Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers
Breast-conserving therapy (BCT) for sporadic breast cancer has been widely accepted by surgeons and patients alike. While BCT is associated with a higher risk of ipsilateral breast tumor recurrence (IBTR), it has not been shown to decrease overall survival (OS) in comparison with mastectomy. Many wo...
Main Authors: | Randal L. Croshaw, Megan L. Marshall, Tesha L. Williams, Kathleen M. Erb, Thomas B. Julian |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.4061/2011/481563 |
Similar Items
-
Prophylactic adnexectomy in BRCA1 and BRCA2 gene mutation carriers (а review of literature)
by: T. A. Shendrikova, et al.
Published: (2014-07-01) -
Prophylactic mastectomy versus surveillance for the prevention of breast cancer in women's BRCA carriers
by: Francisca Honold, et al.
Published: (2018-08-01) -
Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
by: Ellen Warner
Published: (2018-11-01) -
Comparison of risk assessment models of BRCA1 and BRCA2 mutation carrier in patients with breast cancer
by: Rybchenko L.A., et al.
Published: (2013-12-01) -
Molecular biological subtypes of breast cancer in BRCA1 mutation carriers
by: N. I. Pospekhova, et al.
Published: (2021-01-01)